Filtros de búsqueda

Lista de obras de

A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma

artículo científico publicado en 2008

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature

artículo científico publicado en 2013

Ascites due to pericardial cyst

artículo científico publicado en 2009

CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer

artículo científico publicado en 2003

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

scientific article published on 12 November 2019

Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.

artículo científico publicado en 2004

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

artículo científico publicado en 2013

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation

artículo científico publicado en 2020

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

article

Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.

artículo científico publicado en 2003

HLA-DRB1 Donor-Recipient Mismatch Affects the Outcome of Hepatitis C Disease Recurrence After Liver Transplantation

artículo científico publicado en 2006

High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?

artículo científico publicado en 2013

Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?

artículo científico publicado en 2008

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

artículo científico publicado en 2016

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

artículo científico publicado en 2007

Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease

artículo científico publicado en 2002

Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma

artículo científico publicado en 2005

Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection

artículo científico publicado en 2014

Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience

scientific article published on 15 April 2020

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

artículo científico publicado en 2013

Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?

scientific article published on 01 May 2014

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda